Study identifies powerful infection strategy of widespread and potentially lethal virus

December 20, 2012

Scientists at the Gladstone Institutes have mapped the molecular mechanism by which a virus known as cytomegalovirus (CMV) so successfully infects its hosts. This discovery paves the way for new research avenues aimed at fighting this and other seemingly benign viruses that can turn deadly.

Not all viruses are created equal. Some ravage the body quickly, while others—after an initial infection—lie dormant for decades. CMV is one of the eight types of human herpes viruses, a family of viruses that also include (which causes mononucleosis) and -zoster virus (which causes ), and it is one of the world's most rampant. And like other successful viruses, CMV maintains a few key features: it replicates quickly, it evades the host's immune defenses and it keeps the host cell alive just long enough to produce optimal amounts of virus. This last feature helps prevent the virus from building up to toxic levels inside a cell—an action that would kill the cell before the virus had a chance to spread to neighboring cells. To achieve this delicate balance, CMV applies a 'braking mechanism' after initial replication inside the cell. But the underlying process behind this mechanism has long eluded scientists.

Today, researchers in the laboratory of Gladstone Investigator Leor Weinberger, PhD, announce the key to CMV's success: a type of 'accelerator circuit' hidden within the virus' DNA that lets CMV reach optimal levels quickly before the host cell has time to respond—but that also stops the virus from killing the cell before those optimal levels are reached. They report their findings in the latest issue of the journal Cell, now available online.

"CMV infects between 50% and 80% of adults worldwide and can often be transmitted from mother to child during pregnancy," said Dr. Weinberger, who is also an associate professor of biochemistry and biophysics at the University of California, San Francisco (UCSF), with which Gladstone is affiliated. "While CMV usually lies dormant, it can be dangerous or even deadly for the developing fetus or for those with compromised immune systems—such as organ-transplant recipients. As a result, we have long sought to understand exactly how CMV infects cells, in the hopes of developing treatments or a vaccine to diminish its presence around the world."

Dr. Weinberger and his team focused on a small stretch of DNA in CMV's genetic code. Known as Major Immediate-Early Promoter (MIEP), this genetic code kick-starts viral replication by generating IE2, a protein that can be extremely toxic in large quantities. And within MIEP the team discovered the real instigator of viral replication.

In a series of experiments, the team found that when MIEP is activated it not only generates IE2 and spurs replication, but it also cues the virus to stop generating the toxic IE2 protein at the precise moment when optimal levels of IE2 have been reached.

"CMV needs IE2 in order to replicate inside the host cell, but if too much IE2 is produced too quickly, the will be killed before CMV has a chance to spread," said Melissa Teng, a graduate student at the University of California, San Diego (UCSD), a visiting UCSF graduate student and one of the paper's lead authors "But CMV gets around this problem with the so-called 'accelerator circuit,' which helps maintain optimal IE2 levels. This circuit allows CMV to replicate quickly and efficiently, infecting a range of cell types throughout the body."

To confirm these findings, the team infected human cells in dish with two forms of CMV—one of which could generate the IE2 accelerator circuit and one that could not. When they placed both viruses in the same dish, they saw a clear difference. Over time, the viruses without the accelerator circuit disappeared, while the accelerator virus quickly took over the dish. The evidence was clear—this circuit was key to the ' success.

"This impressive work demonstrates a new mechanism for how a relatively simple genetic network can respond to external cues and create the most optimal environment for viral replication," said Gurol Suel, PhD, an associate professor of molecular biology at UCSD who was not involved in the study. "It's quite likely that mechanisms like this one exist in other biological systems, including other viruses."

"The accelerator circuit gives CMV the powerful strategic advantage to outpace systems," said Gladstone Staff Scientist Cynthia Bolovan-Fritts, PhD, the paper's other lead author. "The next step is to understand this mechanism on a deeper level and develop therapeutic approaches to target and disrupt the circuit—and hopefully stop viruses such as CMV in their tracks."

Explore further: How a virus might make you diabetic later in life

Related Stories

How a virus might make you diabetic later in life

August 27, 2012
Cytomegalovirus (CMV) is one of the viruses that most infected people carry without ill effects. Once infected you are infected for life and, although it normally is dormant, it can become active again at any point in time. ...

Researchers show long-term consequences of chronic virus infection

August 16, 2012
The cytomegalovirus (CMV) is a member of the herpesvirus family. Although most people carry CMV for life, it hardly ever makes them sick. Researchers from the Helmholtz Centre for Infection Research and from the USA have ...

Test approved to help treat common infection in transplant patients

July 5, 2012
(HealthDay) -- The first DNA test to help doctors treat a common viral infection in people who have had a solid organ transplant has been approved by the U.S. Food and Drug Administration.

Presence of common infection—cytomegalovirus—helps to explain increased other virus susceptibility in aging adults

September 6, 2012
(Medical Xpress)—The first experimental proof that long-term infection with cytomegalovirus, or CMV, may impair the aging immune system's response to unrelated viruses – such as West Nile or the flu – has been published ...

Recommended for you

Common antiseptic ingredients de-energize cells and impair hormone response

August 22, 2017
A new in-vitro study by University of California, Davis, researchers indicates that quaternary ammonium compounds, or "quats," used as antimicrobial agents in common household products inhibit mitochondria, the powerhouses ...

Researchers offer new targets for drugs against fatty liver disease and liver cancer

August 22, 2017
There may no silver bullet for treating liver cancer or fatty liver disease, but knowing the right targets will help scientists develop the most effective treatments. Researchers in Sweden have just identified a number of ...

Make way for hemoglobin

August 18, 2017
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is ...

Bio-inspired materials give boost to regenerative medicine

August 18, 2017
What if one day, we could teach our bodies to self-heal like a lizard's tail, and make severe injury or disease no more threatening than a paper cut?

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.